A new research report published by Fior Markets with the titleGlobal Leukapheresis Market by Type (Leukapheresis Devices, Leukapheresis Disposables), Application, End-Users, and Region and Global Forecast 2018-2025.

As per the report, theglobal leukapheresis marketis expected to grow from USD 19.29 Million in 2017 to USD 41.07 Million by 2025 at a CAGR of 9.60% during the forecast period from 2018-2025. Asia Pacific is expected to dominate the market during the forecast period. Ongoing regenerative medicine research in the region, rise in the number of clinical trials and the presence of leading pharma and biotech companies in the region are some of the major factors driving the growth of the market in region.

DOWNLOAD FREE SAMPLE REPORT:https://www.fiormarkets.com/report-detail/375981/request-sample

Prominent players operating in the market are Asahi Kasei Medical Co., Ltd, Macopharma SA, Fresenius Se & Co. KGaA, Bioivt, Haemonetics Corporation, PPA Research Group, Inc., Hemacare Corporation, Key Biologics, LLC, Terumo BCT, ALLCells, LLC, Stemexpress, LLC, Stemcell Technologies, Inc., Caltag Medsystems Limited, Zenbio, Inc, Precision for Medicine, Inc and others. Major firms are incorporating various strategies to increase their market reach. For instance, in April 2018, Fresenius Kabi expanded its production site for medical devices in Dominican Republic (U.S). This plant manufactures and exports apheresis systems for plasma and platelet collection. This new production facility has enhanced its production capabilities to meet the demand for apheresis systems.

The type segment is classified into leukapheresis devices and leukapheresis disposables. The leukapheresis disposables segment accounted for the largest market share in 2017. The increasing applications for the isolation of primary cells from blood for cell therapy research applications is estimated to drive the growth of the segment. Applications segment is divided into research applications and therapeutic applications. The research applications segment is dominating and was valued around USD 11.13 million in 2017. Growing adoption in research activities for cancer, immunology, infectious diseases, drug discovery, regenerative medicine, and cell-based therapies are contributing to the growth of the segment. End user segment is classified into blood component providers and blood centers, academic and research institutes, pharmaceutical and biotechnology companies and hospitals and transfusion centers. The blood component providers & blood centers segment is expected to grow with the highest CAGR in the forecast period. Increasing number of blood donations and rising demand for leukopaks in clinical conditions like cancer are driving the growth.

Increasing prevalence of leukemia and rise in the blood donations are boosting demand of market in forecast period. In addition, research activities including development of cell-based immunotherapies is also boosting the growth of the market. High costs of leukapheresis may restrict the growth of the market. However, innovations in R&D activities and commercialization of new products are propelling the growth of the market in forecast period.

ACCESS FULL REPORT:https://www.fiormarkets.com/report/global-leukapheresis-market-by-type-leukapheresis-devices-leukapheresis-375981.html

About the report:The globalleukapheresis market is analysed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porters five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.

Customization of the Report:The report can be customized as per client requirements. For further queries, you can contact us onsales@fiormarkets.comor +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

Contact UsMark StonePhone:+1-201-465-4211Email:sales@fiormarkets.comWeb:www.fiormarkets.com

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.

Read the original post:
Global Leukapheresis Market is Expected to Reach at a CAGR of 9.60% from 2018 to 2025 - PharmiWeb.com